Zentek (CVE:ZEN) Trading Up 17.7% – Still a Buy?

Zentek Ltd. (CVE:ZENGet Free Report) traded up 17.7% during trading on Wednesday . The company traded as high as C$2.48 and last traded at C$2.39. 260,536 shares were traded during mid-day trading, an increase of 528% from the average session volume of 41,460 shares. The stock had previously closed at C$2.03.

Zentek Stock Performance

The stock has a 50 day moving average of C$1.51 and a 200 day moving average of C$1.44. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97. The firm has a market cap of C$245.53 million, a price-to-earnings ratio of -22.55 and a beta of 0.77.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Recommended Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.